PD-L1 expression and efficacy of pembrolizumab as monotherapy in NSCLC

Chin Clin Oncol. 2020 Aug;9(4):60. doi: 10.21037/cco.2020.01.03. Epub 2020 Feb 11.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • B7-H1 Antigen
  • Carcinoma, Non-Small-Cell Lung*
  • Humans
  • Lung Neoplasms*

Substances

  • Antibodies, Monoclonal, Humanized
  • B7-H1 Antigen
  • pembrolizumab